Evaluation of CD271 expression as a prognostic factor in non-small cell lung cancer patients

Evaluation of CD271 expression as a prognostic factor in non-small cell lung cancer patients - Evaluation of CD271 expression as a prognostic factor in non-small cell lung cancer patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046024

Enrollment

200

Registered

2021-11-10

Start date

2021-09-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Non-small cell lung cancer patients who were underwent surgical resection at the Department of Respiratory Surgery, Shiga University of Medical Science Hospital from January 1, 2008 to December 31, 2019

Exclusion criteria

Exclusion criteria: Patients who have refused to allow their samples and information to be used in this research

Design outcomes

Primary

Measure	Time frame
Recurrence-free survival (RFS)	—

Secondary

Measure	Time frame
Overall survival (OS) Association between CD271 staining intensity and clinicopathological findings in non-small cell lung cancer Relationship between the staining intensity of CD271 and the staining intensity of nerve growth factor receptor (NGF, BDGF, Neutrophin) and cancer stromal fibroblast marker molecules (alfa smooth muscle Actin, podoplanin)	—

Countries

Japan

Contacts

Public ContactKeiko Ueda

Shiga University of Medical Science Department of Thoracic Surgery

hqsurg2@belle.shiga-med.ac.jp0775482244

Outcome results